1992•Unpublished venueRequires access

Multicenter trial of salbutamol powder inhalation in treating bronchial asthma in 134 patients

Zheng Li

Abstract

One hundred and thirty-four patients (M92, F42, age 24+16a) with bronchial asthma were treated with salbutamol powder for inhalation (Diskhaler/Ventodisk) Single dose 400ug for adult and 200ug for children, qid for 2 wk. Symptoms were markedly improved within 5 min after inhalation Value of PEFR increased by 20.3%. The mean values of FEV1 and PEFR all increased after therapy (P0.01). The total response rate was 87.3 %.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Salbutamol, Inhalation, Asthma, Medicine, Anesthesia, Internal medicine